2Zhu DL, Herembert T, Caruelle D, et al. Signaling mechanisms of basic fibroblast growth factor in arterial cells from genetically hypertensive rat[J]. Am J Hypertens, 1994,7:351 - 356.
3Shi Y, O'Brien JE Jr, Fard A, et al. Transforming growth factor- beta 1 expression and myofibroblast formation during arterial repair[ J ]. Arterioscler Thromb vasc biol, 1996,16(10) : 1298- 1305.
4Evans RA, Tian YC, Steadman R, et al. TGF- betal - mediated fibroblast - myofibroblast terminal differentiation - the role of Smad proteins[J]. Exp Cell Res, 2003,282(2):90- 100.
5Serini G, Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation[J ]. Exp Cell Res, 1999,250 : 273 - 283.
6Pratschke J,Wilhelm MJ,Kusaka M,et al.A model of gradual onset brain death for transplant-associated studies in rats[J].Transplantation,2000,69(3):427
7Lanza RP,Cooper DK,Novitzky D,et al.Survival after cardiac transplantation[J].S Afr Med J,1983,64(26):1007
8Blaine EM,Tallman RD Jr,Frolicher D,et al.Vasopressin supplementation in a porcine model of brain-dead potential organ donors[J].Transplantation,1984,38(5):459
9Wang QJ,Acs P,Goodnight J,et al.The catalytic domain of PKC-ε,inreciprocal PKC-δ and-ε chimeras,is responsible for conferring tumorgenicity to NIH3T3 cells,whereas both regulatory and catalyticdomins of PKC-ε contribute to in vitro transformation[J].Oncogene,1998,16(1):53
10Togashi H,Hirshrnan CA,Emala CW.Qualitative immunoblot analysis of PKC isoforms expressed in airway smooth muscle[J].Am J Physiol,1997,272(4 Pt 1):L603
